NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

She stated in late 2014 that she intended to take the trial out past all the IAs... or basically that she intended to not stop early. Now she had likely hoped to unblind based on the PFS endpoint, and then of course, use OS as the confirmation trial. So perhaps they opted to do blinded data analysis in order to be able to revised the protocol and SAP if necessary. If that was the case, then that ended up to be a very good, albeit unpopular decision.